Pyxis Oncology, Inc.: shareholders and insiders

PYXSNASDAQHealthcare · Pharmaceutical Preparations

Price

$1.81

November 20, 2026Market cap $216M

What Ploutos Investor adds for Pyxis Oncology

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 2 fiscal years, from 2024
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Insiders and their shares

Purchases and sales by officers and directors from Nov 22, 2025 to Nov 6, 2026, from their own Form 4 filings.

6 Form 4s

Bought on the market

–

1 person

Sold on the market

$107.1K

1 person

From Nov 22, 2025 to Nov 22, 2026, the days the chart shows. Change its range and the figures follow.

How the sales were made, as a share of their value

  • Under a set plan100%
  • The rest0%

By year

Insiders' open-market purchases (up) and sales (down), by value, since Nov 22, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.

2026·bought $0 by 1 person·sold $107.1K by 1 person

  • 2025: no buys, no sales
  • 2026: bought $0 by 1 person, sold $107.1K by 1 person
  • Oct 1, 2026GordonMD Global Investments LP
    Kind
  • Jun 30, 2026Jakob DupontDirector
    Kind10b5-1
  • Jun 30, 2026Jakob DupontDirector
    Kind10b5-1

From the Form 4s insiders file with the SEC within two business days of each trade.

Insiders and their shares

Every buy and sale by PYXS's officers and directors from 2021 up to November 21, 2025, 5 more calendar years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 3 years.

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

5 Holders over 5%1 On a 13DNov 3, 2026 Latest filing
  • GordonMD Global Investments LPwith 3 more persons
    Share of class16.4%
  • Lara Sullivan, M.D.
    Share of class11.2%
  • Biotechnology Value Fund L Pwith 9 more persons
    Share of class9.99%
  • Coastlands Capital LPwith 4 more persons
    Share of class5.42%
  • Laurion Capital Management LPwith 2 more persons
    Share of class5.16%
Fell to 5% or less (4)

Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.

  • Millennium Management LLC1.30%Oct 14, 202513G/A
  • BlackRock, Inc.1.50%Jul 17, 202513G/A
  • Ridgeback Capital Investments L.P.0.60%Feb 14, 202513G/A
  • Deep Track Capital, LP0.00%Feb 14, 202513G/A

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Sep 30, 2026 quarter end
  • Point72 (Cohen)
    In the quarter
  • Citadel Advisors (Griffin)
    In the quarter+319%
  • Millennium Mgmt (Englander)
    In the quarter+257%
  • Renaissance Technologies
    In the quarter-52%

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 3.63% of its shares outstanding were held short, -11.1% since the report before.

Shares held short
4.35M
3.63%
Since the report before4.89M on Sep 30, 2026
-11.1%
3.5
1.25M
More days to cover thanof 4,578 US-listed companies with enough volume
41%
Report date
Oct 15, 2026
  • Oct 31, 2023: Shares held short 792.5K
  • Nov 15, 2023: Shares held short 801.1K
  • Nov 30, 2023: Shares held short 745.8K
  • Dec 15, 2023: Shares held short 674.6K
  • Dec 29, 2023: Shares held short 634.0K
  • Jan 12, 2024: Shares held short 611.1K
  • Jan 31, 2024: Shares held short 784.6K
  • Feb 15, 2024: Shares held short 1.28M
  • Feb 29, 2024: Shares held short 1.34M
  • Mar 15, 2024: Shares held short 1.63M
  • Mar 28, 2024: Shares held short 2.70M
  • Apr 15, 2024: Shares held short 2.21M
  • Apr 30, 2024: Shares held short 1.85M
  • May 15, 2024: Shares held short 1.96M
  • May 31, 2024: Shares held short 2.19M
  • Jun 14, 2024: Shares held short 2.31M
  • Jun 28, 2024: Shares held short 2.31M
  • Jul 15, 2024: Shares held short 3.52M
  • Jul 31, 2024: Shares held short 3.99M
  • Aug 15, 2024: Shares held short 4.02M
  • Aug 30, 2024: Shares held short 3.81M
  • Sep 13, 2024: Shares held short 3.77M
  • Sep 30, 2024: Shares held short 4.22M
  • Oct 15, 2024: Shares held short 4.91M
  • Oct 31, 2024: Shares held short 5.86M
  • Nov 15, 2024: Shares held short 5.84M
  • Nov 29, 2024: Shares held short 6.08M
  • Dec 13, 2024: Shares held short 6.40M
  • Dec 31, 2024: Shares held short 7.34M
  • Jan 15, 2025: Shares held short 7.42M
  • Jan 31, 2025: Shares held short 7.00M
  • Feb 14, 2025: Shares held short 6.88M
  • Feb 28, 2025: Shares held short 7.01M
  • Mar 14, 2025: Shares held short 6.92M
  • Mar 31, 2025: Shares held short 7.34M
  • Apr 15, 2025: Shares held short 7.13M
  • Apr 30, 2025: Shares held short 7.23M
  • May 15, 2025: Shares held short 7.05M
  • May 30, 2025: Shares held short 6.47M
  • Jun 13, 2025: Shares held short 6.18M
  • Jun 30, 2025: Shares held short 5.06M
  • Jul 15, 2025: Shares held short 4.78M
  • Jul 31, 2025: Shares held short 4.70M
  • Aug 15, 2025: Shares held short 5.03M
  • Aug 29, 2025: Shares held short 4.33M
  • Sep 15, 2025: Shares held short 4.36M
  • Sep 30, 2025: Shares held short 4.13M
  • Oct 15, 2025: Shares held short 4.25M
  • Oct 31, 2025: Shares held short 4.36M
  • Nov 14, 2025: Shares held short 4.54M
  • Nov 28, 2025: Shares held short 4.52M
  • Dec 15, 2025: Shares held short 1.93M
  • Dec 31, 2025: Shares held short 1.73M
  • Jan 15, 2026: Shares held short 2.31M
  • Jan 30, 2026: Shares held short 2.39M
  • Feb 13, 2026: Shares held short 2.44M
  • Feb 27, 2026: Shares held short 2.53M
  • Mar 13, 2026: Shares held short 2.49M
  • Mar 31, 2026: Shares held short 2.66M
  • Apr 15, 2026: Shares held short 2.27M
  • Apr 30, 2026: Shares held short 1.99M
  • May 15, 2026: Shares held short 1.81M
  • May 29, 2026: Shares held short 1.74M
  • Jun 15, 2026: Shares held short 2.02M
  • Jun 30, 2026: Shares held short 2.29M
  • Jul 15, 2026: Shares held short 3.25M
  • Jul 31, 2026: Shares held short 4.17M
  • Aug 14, 2026: Shares held short 4.43M
  • Aug 31, 2026: Shares held short 3.97M
  • Sep 15, 2026: Shares held short 4.68M
  • Sep 30, 2026: Shares held short 4.89M
  • Oct 15, 2026: Shares held short 4.35M

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading50.4% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 50.4% of the shares in the reported trades were short sales, against 50.2% in the 14 before.

Last 14 sessionsNov 3, 2026 – Nov 20, 2026
50.4%
The 14 beforeOct 14, 2026 – Nov 2, 2026
50.2%
Change
+0.2 pts
Short sales a dayon average, of 518.3K shares
261.2K
More than atof 3,666 US-listed companies, same days
50%
Median of alleight in ten from 34.4% to 63.9%
50.5%
  • Oct 14, 2026: Short sales 33.3%
  • Oct 15, 2026: Short sales 48%
  • Oct 16, 2026: Short sales 55.9%
  • Oct 19, 2026: Short sales 52.9%
  • Oct 20, 2026: Short sales 54%
  • Oct 21, 2026: Short sales 51.6%
  • Oct 22, 2026: Short sales 52.5%
  • Oct 23, 2026: Short sales 48.6%
  • Oct 26, 2026: Short sales 56.8%
  • Oct 27, 2026: Short sales 39.8%
  • Oct 28, 2026: Short sales 54.6%
  • Oct 29, 2026: Short sales 38.8%
  • Oct 30, 2026: Short sales 48.3%
  • Nov 2, 2026: Short sales 74.1%
  • Nov 3, 2026: Short sales 63.1%
  • Nov 4, 2026: Short sales 49%
  • Nov 5, 2026: Short sales 38.8%
  • Nov 6, 2026: Short sales 52.1%
  • Nov 9, 2026: Short sales 67.2%
  • Nov 10, 2026: Short sales 55.3%
  • Nov 11, 2026: Short sales 76.1%
  • Nov 12, 2026: Short sales 76.4%
  • Nov 13, 2026: Short sales 62.8%
  • Nov 16, 2026: Short sales 56%
  • Nov 17, 2026: Short sales 38.9%
  • Nov 18, 2026: Short sales 47.8%
  • Nov 19, 2026: Short sales 43.6%
  • Nov 20, 2026: Short sales 40.8%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

What the insiders hold

The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.

16.86M Insiders' shares26.84% Of the company
  • GordonMD Global Investments LP
    Directly15.54M
  • Pamela Ann ConnealyCFO & COO
    Directly–
  • Rachel HumphreyDirector
    Directly81.3K
  • Jakob DupontDirector
    Directly38.7K

A lower bound: it counts only the 4 officers and directors with a market trade since Nov 23, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.

The ETFs that hold it

Which of the 349 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.

4 ETFs holding it0.03% The largest weight (IWC)
  • IWCiShares Micro-Cap ETF
    Weight in the fund0.03%
  • IBBiShares Biotechnology ETF
    Weight in the fund0.01%
  • VXFVanguard Extended Market Index Fund
    Weight in the fund0.00%
  • VTIVanguard Total Stock Market Index Fund
    Weight in the fund0.00%

4 of the 349 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

76 Managers, Q2 2026$101M Value of their positions
  • Q3 2025: Managers 73
  • Q4 2025: Managers 79
  • Q1 2026: Managers 79
  • Q2 2026: Managers 76

Institutional investors by quarter

The fund managers holding PYXS, quarter by quarter, from Q4 2021 to Q2 2025, 15 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 12 quarters.

Q2 2026: 76 managers held 34.15M shares, worth $101M. During the quarter 9 opened a position, 12 closed one, 23 added and 24 trimmed.

The largest holders, Q2 2026

  • GordonMD Global Investments
    In the quarter+143%
  • Pfizer
    In the quarter
  • Laurion Capital Management
    In the quarter-1.9%
  • Vanguard Capital Management
    In the quarter+2.1%
  • Atle Fund Management AB
    In the quarter+390%
  • BlackRock
    In the quarter+10%
  • Palo Alto Investors
    In the quarter-14%
  • Marshall Wace
    In the quarter+134%
  • Renaissance Technologies
    In the quarter-13%
  • Geode Capital Management
    In the quarter-1.0%

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.

The full analysis

What do Pyxis Oncology's filings show?

Who buys and sells is one part of Pyxis Oncology's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about PYXS's shareholders

Didn't find what you were looking for?

Ask us
Have PYXS's insiders bought or sold?

From Jul 2, 2026 to Nov 6, 2026 Pyxis Oncology's insiders bought 0 and sold $107.1K of shares on the market. 100% of the sales were under set 10b5-1 plans.

Which well-known managers hold PYXS?

4 of the managers we track held the shares on Sep 30, 2026. The largest position was Millennium Mgmt (Englander)'s, worth $1.9M.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.